狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > pAS2 [pAS1-CYH2]
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
pAS2 [pAS1-CYH2]
pAS2 [pAS1-CYH2]
規格:
貨期:
編號:B192547
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 pAS2 [pAS1-CYH2]
商品貨號 B192547
Designations pAS2 [pAS1-CYH2]
Depositors SJ Elledge
Biosafety Level 1
Vector Information
Size (kb): 8.5000000000000000
Vector: pAS2 (phagemid)
Promoters: Promoter ADC1 (ADH)
Construction: pAS1
Marker(s):TRP1,ampR,cyhS
Features: marker(s): CYH2
marker(s): TRP1
marker(s): ampR
other: GAL4 DNA-binding domain
promoter: ADC1 (ADH)
replicon: 2 micron
replicon: f1+
replicon: pMB1
MCS: NdeI...SalI
terminator: ADC1
epitope tag: hemagglutinin (HA)
Applications
YE-type (episomal) shuttle vector
contains sequence ribosomal protein L29 Ribosomal protein RL43
expression vector
shuttle vector
vector for constructing cDNA libraries
vector for other uses
Comments
Restriction digests of the clone give the following sizes (kb): BamHI--8.6; SalI--8.6; SmaI--8.6.
Shuttle expression vector used to create fusion proteins consisting of the nuclear localization sequence from SV40 T antigen, the GAL4 DNA-binding domain (aa 1-147), and a HA (hemagglutinin) epitope tag in frame with the activation domain.
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C
References

Harper JW, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993. PubMed: 8242751

Shipped freeze-dried
Shipping Information

?Freeze dried E. coli containing the plasmid

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |